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BACKGROUND: Empirical data on the link between stress and 
cardiovascular disease (CVD) risk among black women is limited. We 
examined associations of stressful life events and social strain with 
incident CVD among black women and tested for effect modification by 
resilience.
METHODS AND RESULTS: Our analysis included 10 785 black women 
enrolled in the Women’s Health Initiative Observational Study and Clinical 
Trials cohort. Participants were followed for CVD for up to 23 years 
(mean, 12.5). Multivariable Cox regression was used to estimate hazard 
ratios and 95% CIs for associations between stress-related exposures and 
incident CVD. We included interactions between follow-up time (age) 
and stressful life events because of evidence of nonproportional hazards. 
Effect modification by resilience was examined in the sub-cohort of 2765 
women with resilience and stressful life events measures. Higher stressful 
life events were associated with incident CVD at ages 55 (hazard ratio for 
highest versus lowest quartile=1.80; 95% CI, 1.27–2.54) and 65 (hazard 
ratio for highest versus lowest quartile=1.40; 95% CI, 1.16–1.68), but 
not at older ages. Adjustment for CVD risk factors attenuated these 
associations. Similar associations were observed for social strain. In the 
sub-cohort of women with updated stressful life events and resilience 
measures, higher stressful life events were associated with incident CVD 
in multivariable-adjusted models (hazard ratio=1.61; 95% CI, 1.04–2.51). 
Resilience did not modify this association nor was resilience independently 
associated with incident CVD.
CONCLUSIONS: In this cohort of older black women, recent reports of 
stressful life events were related to incident CVD. Resilience was unrelated 
to incident CVD.
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Cardiovascular disease (CVD) mortality has de-clined dramatically in the United States. This de-cline has paralleled advances in primary preven-
tion, including improved hypertension treatment and 
control, smoking reductions, and the prevalent use 
of statins, as well as the use of early interventions in 
those with atherosclerotic events.1,2 Age-adjusted an-
nual heart disease mortality fell by 56% between 1950 
and 1996, whereas age-adjusted annual stroke rates 
fell by 70% during the same period.3 However, these 
reductions have not been equitably experienced across 
the US population. In particular, black women continue 
to experience a higher burden of CVD compared with 
their white counterparts.3–5 These differences appear to 
persist, even after accounting for traditional CVD risk 
factors. As such, the continued disparate health out-
comes experienced by black women mandate addition-
al research into the etiology and preventive strategies 
for CVD among black women.
Stress is hypothesized to contribute to CVD through 
inflammation, endothelial dysfunction, and athero-
sclerosis.6 In an analysis of the Women’s Health Ini-
tiative (WHI) Observational Study (OS),7 higher social 
strain and stressful life events were associated with 
increased risk of coronary heart disease and stroke in 
models adjusted for sociodemographic characteristics 
and depressive symptoms; however, subsequent inclu-
sion of potential mediating factors, including alcohol 
use, cigarette smoking, hypertension, waist circum-
ference, high cholesterol, diabetes mellitus, physical 
activity, and dietary quality attenuated these relation-
ships. These associations were not modified by race, 
suggesting similar relationships among white and 
black women.
Stress may be particularly relevant for black women, 
given the discriminatory environment in which these 
women may live. However, research on the relationship 
between stress and CVD among black women is sparse. 
Furthermore, resilience, or the ability to bounce back 
from adversity, may mitigate some of the harmful effects 
of stress and CVD risk factors. Emerging data suggest 
that at-risk populations, including individuals stigmatized 
because of their race/ethnicity, have developed culturally-
specific mechanisms that help them not only survive, but 
also thrive.8 Although the potential moderating effect of 
resilience has not been specifically explored in the context 
of stress and CVD among black women, resilience has 
been identified as a protective factor in the relationship 
between substance abuse, violence, and HIV/AIDS with 
depressive symptoms among black women.9
We sought to build on the prior WHI analysis by 
examining the association between stress and incident 
CVD in a larger population of black women and evalu-
ating whether resilience modifies this relationship. We 
hypothesized that higher self-reports of stressful life 
events and social strain are associated with increased 
incident CVD among black women. Moreover, we pos-
tulated that high levels of resilience may attenuate the 




Because of the sensitive nature of the data collected for this 
study, requests to access the dataset from qualified research-
ers trained in human subject confidentiality protocols may be 
sent to the Women’s Health Initiative at www.whi.org. Full 
details of the WHI have been described previously.10–12 Briefly, 
between 1993 and 1998, postmenopausal women between 
the ages of 50 and 79 years were recruited from 40 clinical 
sites across the US into 1 or more randomized clinical trials 
(WHI-CT, n=68 132) or an OS (WHI-OS, n=93 676). Women in 
the WHI-OS were either unwilling or ineligible to be included 
in the WHI-CT.13 Moreover, black women were oversampled 
in the WHI-OS. The WHI-CT and WHI-OS were closed in 2004 
to 2005, and participants were invited to continue follow-up 
in the WHI Extension Study 1 (2005–2010), Extension Study 
2 (2010–2015), and Extension Study 3 (2015–2020). Written 
informed consent was obtained from all study participants. 
Ethics approval was obtained from institutional review boards 
at all participating institutions. A standardized written proto-
col, centralized training of staff, and quality assurance visits 
by the Clinical Coordinating Center were used to ensure uni-
form data collection.13
Our study sample was drawn from the 161 808 women 
participating in either the WHI-CT or WHI-OS. Of these, 
we excluded non-black women (n=147 190), women miss-
ing baseline stressful life events or social strain measures 
(n=1322), women with a history of CVD at baseline (n=2435), 
and women who were missing follow-up time (n=76), leaving 
10 785 women in our analytic sample.
WHAT IS KNOWN
• Black women have a higher burden of cardiovas-
cular disease (CVD) compared with their white
counterparts.
• Stress is modestly associated with higher risk of
CVD in mostly white study populations.
WHAT THE STUDY ADDS
• Higher baseline stressful life events and social
strain were associated with higher CVD risk among 
black women; however, adjustment for traditional
CVD risk factors attenuated these associations.
• In a sub-cohort of women with updated stressful
life events and resilience measures, higher stress-
ful life events were independently associated with
higher incident CVD.
• Resilience was not independently associated with
CVD risk nor did it modify the association between
stressful life events and CVD risk.
Exposure Variables
At baseline, women completed questionnaires on stressful 
life events and social strain. The stressful life events question-
naire was adapted from the Beta-Blocker Heart Attack Trial 
and modified for women of older age.14 Participants indicated 
whether any of 11 life changes had occurred over the past 
year: spouse died, spouse had serious illness, close friend 
died, had major problems with money, experienced a divorce 
or break up, close friend divorced, major conflict with children 
or grandchildren, lost job, physically abused, verbally abused, 
and pet died. Additionally, women were asked to appraise 
each of the 11 life events that occurred based on the degree 
of upset that it caused on a scale of 1 (did not upset me) to 
3 (upset me very much), generating a scale ranging from 0 
to 33, with higher scores indicating greater stressful events.
Social strain was derived from 4 items from a previously 
validated measure of negative aspects of social relationships.15 
Participants were asked how many of the people who were 
important to them got on their nerves, asked too much of 
them, did not include them, or tried to get them to do things 
they do not want to do. Responses to each item ranged from 
1 (none) to 5 (all), yielding a social strain score ranging from 4 
to 20, with higher scores indicating greater social strain.
Resilience, or the ability to bounce back from stressful situ-
ations, was assessed during the WHI Extension Study 2 and 
quantified with the modified Brief Resilience Scale.16 Of the 6 
items included in the original Brief Resilience Scale, scoring of 
3 items was available in the WHI study. Participants are asked 
to rate the following statements on a scale of 1 to 6: “I tend 
to bounce back quickly after hard times; It does not take me 
long to recover from a stressful event; I have a hard time mak-
ing it through stressful events.” Scores range from 3 to 18, 
with higher scores indicating higher resilience.
Other Covariates
At baseline, participants completed self-administered ques-
tionnaires detailing demographic characteristics, medical 
and reproductive history, previous use of postmenopausal 
hormone therapy, physical activity, smoking history, alcohol 
use, diet, and other risk factors. Physical activity was quanti-
fied with questions on frequency, duration, and intensity of 
participation in different forms of physical activity. Weekly 
recreational physical activity was calculated by multiplying an 
assigned energy expenditure level for each category of activ-
ity by the hours exercised per week to calculate total meta-
bolic equivalents per week (METs per week). Participants also 
underwent a clinic visit where trained staff measured each 
participant’s height and weight using a standardized protocol. 
Body mass index was calculated based on these height and 
weight measurements.
Outcome Variables
The primary outcome of our analysis was time to any CVD 
event, including coronary heart disease (angina and myocar-
dial infarction), revascularization procedure (coronary revas-
cularization, percutaneous transluminal coronary angioplasty, 
carotid revascularization, and coronary artery bypass graft), 
carotid artery disease, peripheral artery disease, stroke/tran-
sient ischemic attack, heart failure, and CVD-related death. 
These events were centrally adjudicated using standardized 
case definitions and clinical criteria and updated annually 
through December 31, 2015 (end of Extension Study 2). 
Death certificate and medical record reviews were used to 
determine cause of death. A 94% rate of agreement between 
local and central clinical adjudicators for cause of death in 
WHI has been previously reported.17
Statistical Analysis
Summary statistics of baseline characteristics according to 
stressful life events and social strain were evaluated with χ2 
tests or t tests, respectively. Stressful life events and social 
strain were investigated in 4 categories (based on quartiles) 
and as continuous variables. We estimated hazard ratios 
(HRs) and 95% CIs for the association between stressful life 
events, social strain, and incident CVD using the Cox propor-
tional hazards regression model. Age at study randomiza-
tion/enrollment was used as the underlying time scale, and 
women who died from non-CVD events were censored. We 
tested the proportional hazards assumption by examining the 
Wald test for the multiplicative interaction between our main 
exposure variables, stressful life events and social strain, and 
follow-up time (natural log scale). Due to evidence of non-
proportional hazards for baseline stressful life events, but not 
social strain, we included a multiplicative interaction between 
baseline stressful life events and age to allow for nonpropor-
tional hazards. We present age-specific HRs and 95% CIs to 
illustrate the time-varying relationship of baseline stress on 
incident CVD as women age. All models were adjusted for 
known CVD risk factors, including diabetes mellitus status 
(no, yes), body mass index (<25 kg/m2, 25–30 kg/m2, ≥30 kg/
m2), physical activity (>0–3.75 MET-h/wk, 3.75–8.75 MET-h/
wk, 8.75–17.5 MET-h/wk, ≥17.5 MET-h/wk), hypertension 
history (none, treated hypertension, or untreated hyperten-
sion), use of antihyperlipidemia drugs (no, yes), smoking sta-
tus (never, past, and current), and education (less than high 
school or general equivalency diploma, high school diploma 
or general equivalency diploma, some college, college gradu-
ate or higher).
We also examined whether resilience modified the effect 
of stressful life events and incident CVD using the likelihood-
ratio procedure, comparing models with and without an 
interaction term between resilience and stressful life events. 
This analysis included the subset of black women who 
responded to the Extension Study 2 questionnaire. We did 
not examine interactions with social strain, as this was not 
included in the Extension Study 2 questionnaire. Analyses 
were conducted using STATA software (version 11, STATA 
Corp, Texas). All P values were 2-sided with the probability of 
a type I error set at <5%.
RESULTS
Study Population
Compared with black women in the lowest quartile of 
stressful life events, women in the highest quartile of 
stressful life events were younger at baseline, had lower 
educational attainment, were less physically active, and 
had a higher proportion of current smoking, obesity, 
Table 1. Baseline Characteristics of Study Participants by Stressful Life Events, Women’s Health Initiative 
Observational and Clinical Trials, n=10 785
Stressful Life Events
Q1 (0–1) Q2 (2–3) Q3 (4–6) Q4 (7–30)
(n=2495) (n=2917) (n=2966) (n=2407)
Age at WHI entry mean (SD) 61.7 (7) 61.4 (7.1) 60.8 (7) 60.0 (6.8)
Education
 Missing 22 (1%) 31 (1%) 31 (1%) 42 (2%)
 Less than high school diploma or GED 226 (9%) 256 (9%) 291 (10%) 317 (13%)
 High school diploma or GED 342 (14%) 397 (14%) 395 (13%) 323 (13%)
 Some college 897 (36%) 1066 (37%) 1170 (39%) 1014 (42%)
 College graduate or higher 1008 (40%) 1167 (40%) 1079 (36%) 711 (30%)
Smoking status
 Missing 46 (2%) 35 (1%) 45 (2%) 35 (1%)
 Never smoked 1286 (52%) 1444 (50%) 1425 (48%) 1133 (47%)
 Past smoker 933 (37%) 1142 (39%) 1122 (38%) 932 (39%)
 Current smoker 230 (9%) 296 (10%) 374 (13%) 307 (13%)
BMI
 Missing 25 (1%) 28 (1%) 25 (1%) 23 (1%)
 <25 kg/m2 443 (18%) 506 (17%) 464 (16%) 329 (14%)
 25 to 29 kg/m2 886 (36%) 984 (34%) 991 (33%) 712 (30%)
 ≥30 kg/m2 1141 (46%) 1399 (48%) 1486 (50%) 1343 (56%)
Hormone use
 Missing 4 (<1%) 2 (<1%) 4 (<1%) 6 (<1%)
 Never 1446 (58%) 1701 (58%) 1727 (58%) 1456 (60%)
 Past user 383 (15%) 420 (14%) 443 (15%) 352 (15%)
 Current user <5 y 267 (11%) 291 (10%) 313 (11%) 263 (11%)
 Current user 5 to <10 y 141 (6%) 195 (7%) 187 (6%) 126 (5%)
 Current user ≥10 y 254 (10%) 308 (11%) 292 (10%) 204 (8%)
Type of hormone use
 Missing 4 (<1%) 2 (<1%) 4 (<1%) 6 (<1%)
 Never user 1446 (58%) 1701 (58%) 1727 (58%) 1456 (60%)
 Past user of either E alone or E+P 383 (15%) 420 (14%) 443 (15%) 352 (15%)
 E alone  498 (20%) 599 (21%) 574 (19%) 458 (19%)
 E+P 164 (7%) 195 (7%) 218 (7%) 135 (6%)
Oral contraceptive use
 Missing 0 0 0 1 (<1%)
 Yes 905 (36%) 1142 (39%) 1216 (41%) 1039 (43%)
Diabetes mellitus status
 Missing 6 (<1%) 7 (<1%) 5 (<1%) 2 (<1%)
 Yes 222 (9%) 279 (10%) 301 (10%) 287 (12%)
Use of antihyperlipidemia drugs
 Missing 125 (5%) 186 (6%) 188 (6%) 173 (7%)
 Yes 328 (13%) 391 (13%) 359 (12%) 303 (13%)
Hypertension history
 Missing 112 (4%) 164 (6%) 169 (6%) 145 (6%)
 Never hypertensive 1187 (48%) 1333 (46%) 1335 (45%) 1050 (44%)
 Treated hypertensive 993 (40%) 1191 (41%) 1200 (40%) 973 (40%)
(Continued )
oral contraceptive use, and diabetes mellitus (Table 1). 
Black women in the highest quartile of social strain 
were more commonly never users of menopausal hor-
mone therapy compared with those in the lowest quar-
tile of social strain (Table 2).
Baseline Stressful Life Events, Social 
Strain, and Incident CVD
During a mean 12.5 years of follow-up, 1863 wom-
en (17%) experienced a CVD event, at a mean age of 
72.6 years. Angina was the most common CVD event 
(n=636; 34%), followed by stroke (n=348; 19%), coro-
nary heart disease (n=308; 17%), and congestive heart 
failure (n=302, 16%). In univariable models, higher 
baseline reports of stressful life events were associated 
with higher incident CVD at ages 55 (HR for highest 
versus lowest quartile =1.80; 95% CI, 1.27–2.54) and 
65 (HR for highest versus lowest quartile =1.40; 95% 
CI, 1.16–1.68). In multivariable models that adjusted for 
established CVD risk factors, the association between 
stressful life events and incident CVD was no longer 
significant (Table 3 and Figure). Similarly, we observed a 
univariable association between higher baseline reports 
of social strain and incident CVD (HR for highest ver-
sus lowest quartile =1.30; 95% CI, 1.13–1.49) that was 
attenuated in the multivariable models (HR, 1.13; 95% 
CI, 0.97–1.31). Associations between established CVD 
risk factors and CVD events were in the expected direc-
tions in the multivariable-adjusted model. For example, 
diabetes mellitus (HR, 2.25; 95% CI, 1.98–2.56), obe-
sity HR, 1.18; 95% CI, 1.06–1.32), physical inactivity 
(HR, 1.27; 95% CI, 1.09–1.49), and current smoking 
(HR, 2.05; 95% CI, 1.76–2.38) were all related to high-
er CVD event risk.
Modifying Role of Resilience
Among the 10 785 black women included in the base-
line analyses, 2765 (25.6%) had data on resilience and 
stressful life events from the Extension Study 2 ques-
tionnaire. Associations between resilience, stressful life 
events, and baseline factors are shown in Table 4. Black 
women in the highest quartile of resilience reported 
lower stress, had higher educational attainment, were 
less likely to be obese, more commonly used oral con-
traceptives, less commonly used antihyperlipidemia 
drugs, and were more physically active compared with 
black women in the lower quartile of resilience.
Of the Extension Study 2 cohort, 202 (7.3%) expe-
rienced a CVD event, with a mean age at first CVD 
event of 79.5 years (SD, 6.6 years; range, 64.6–96.3 
years). We observed no interaction between resilience 
and stressful life events in either a univariable (P=0.74) 
or multivariable Cox proportional hazards model for 
incident CVD (P=0.48). Therefore, we present the mul-
tivariable-adjusted main effects of stressful life events 
and resilience in relation to incident CVD in Table 5. 
Similar to estimates in the overall cohort, higher stress-
ful life events was positively associated with incident 
CVD (HR for highest versus lowest quartile =1.61; 
95% CI, 1.04–2.51; Q2 versus Q1 HR, 1.83; 95% CI, 
1.19–2.82) even after accounting for CVD risk factors. 
However, resilience was not associated with incident 
 Untreated hypertensive 203 (8%) 229 (8%) 262 (9%) 239 (10%)
Physical activity
 Missing 77 (3%) 125 (4%) 135 (5%) 108 (4%)
 None 513 (21%) 639 (22%) 641 (22%) 565 (23%)
 >0–3.75 MET-h/wk 436 (17%) 478 (16%) 540 (18%) 461 (19%)
 3.75–8.75 MET-h/wk 515 (21%) 584 (20%) 614 (21%) 473 (20%)
 8.75–17.5 MET-h/wk 463 (19%) 513 (18%) 502 (17%) 404 (17%)
 ≥17.5 MET-h/wk 491 (20%) 578 (20%) 534 (18%) 396 (16%)
WHI trial membership
 OS 1340 (54%) 1495 (51%) 1444 (49%) 1180 (49%)
 E only  158 (6%) 177 (6%) 224 (8%) 187 (8%)
 E+P 108 (4%) 154 (5%) 158 (5%) 126 (5%)
 DM 741 (30%) 878 (30%) 904 (30%) 704 (29%)
 E+P and DM 148 (6%) 213 (7%) 236 (8%) 210 (9%)
DM indicates dietary modification; E, estrogen; GED, general equivalency diploma; MET, metabolic equivalent; OS, 
observational study; and P, progestin.
Table 1. Continued
Stressful Life Events
Q1 (0–1) Q2 (2–3) Q3 (4–6) Q4 (7–30)
(n=2495) (n=2917) (n=2966) (n=2407)
Table 2. Baseline Characteristics of Study Participants by Social Strain, Women’s Health Initiative Observational and Clinical 
Trials, n=10 785
Social Strain
Q1 (4) Q2 (5–6) Q3 (7–9) Q4 (10–20)
(n=2649) (n=3220) (n=2477)  (n=2439)
Age at WHI entry mean (SD) 61.3 (7) 60.8 (7) 60.3 (6.8) 61.8 (7.2)
Education
 Missing 22 (1%) 40 (1%) 39 (2%) 25 (1%)
 Less than high school diploma or GED 207 (8%) 288 (9%) 376 (15%) 219 (9%)
 High school diploma or GED 308 (12%) 459 (14%) 368 (15%) 322 (13%)
 Some college 1011 (38%) 1289 (40%) 1009 (41%) 838 (34%)
 College graduate or higher 1101 (42%) 1144 (36%) 685 (28%) 1035 (42%)
Smoking status
 Missing 52 (2%) 43 (1%) 36 (1%) 30 (1%)
 Never smoked 1297 (49%) 1593 (49%) 1173 (47%) 1225 (50%)
 Past smoker 1016 (38%) 1220 (38%) 936 (38%) 957 (39%)
 Current smoker 284 (11%) 364 (11%) 332 (13%) 227 (9%)
BMI
 Missing 27 (1%) 34 (1%) 17 (1%) 23 (1%)
 <25 kg/m2 503 (19%) 524 (16%) 298 (12%) 417 (17%)
 25–29 kg/m2 895 (34%) 1052 (33%) 738 (30%) 888 (36%)
 ≥30 kg/m2 1224 (46%) 1610 (50%) 1424 (57%) 1111 (46%)
Hormone use
 Missing 6 (<1%) 4 (<1%) 3 (<1%) 3 (<1%)
 Never 1456 (55%) 1919 (60%) 1483 (60%) 1472 (60%)
 Past user 452 (17%) 450 (14%) 351 (14%) 345 (14%)
 Current user <5 y 275 (10%) 340 (11%) 259 (10%) 260 (11%)
 Current user 5 to <10 y 180 (7%) 190 (6%) 157 (6%) 122 (5%)
 Current user ≥10 y 280 (11%) 317 (10%) 224 (9%) 237 (10%)
Type of hormone use
 Missing 6 (<1%) 4 (<1%) 3 (<1%) 3 (<1%)
 Never user 1456 (55%) 1919 (60%) 1483 (60%) 1472 (60%)
 Past user of either E alone or E+P 452 (17%) 450 (14%) 351 (14%) 345 (14%)
 E alone  561 (21%) 618 (19%) 489 (20%) 461 (19%)
 E+P 174 (7%) 229 (7%) 151 (6%) 158 (6%)
Oral contraceptive use
 Missing 1 (<1%) 0 0 0
 Yes 1026 (39%) 1343 (42%) 1025 (41%) 908 (37%)
Diabetes mellitus status
 Missing 6 (<1%) 4 (<1%) 5 (<1%) 5 (<1%)
 Yes 235 (9%) 311 (10%) 306 (12%) 237 (10%)
Use of antihyperlipidemia drugs
 Missing 178 (7%) 212 (7%) 163 (7%) 119 (5%)
 Yes 342 (13%) 404 (13%) 346 (14%) 289 (12%)
Hypertension history
 Missing 157 (6%) 192 (6%) 132 (5%) 109 (4%)
 Never hypertensive 1229 (46%) 1445 (45%) 1060 (43%) 1171 (48%)
 Treated hypertensive 1037 (39%) 1314 (41%) 1028 (42%) 978 (40%)
(Continued )
CVD (HR for lowest versus highest quartile =0.95; 
95% CI, 0.63–1.42).
DISCUSSION
In this large study of older black women, we observed 
associations between baseline reports of higher stress-
ful life events and increased incident CVD that dimin-
ished with age. Moreover, the age-specific associations 
were subsequently attenuated when conventional CVD 
risk factors were accounted. Likewise, higher social 
strain was related to incident CVD, but associations 
were attenuated with CVD risk factor adjustment. In 
the sub-cohort of women with updated information on 
stressful life events, we observed a significant associa-
tion with CVD that was independent of CVD risk fac-
tors. Yet, contrary to our hypothesis, the relationship 
between stressful life events and incident CVD was not 
modified by resilience, nor was resilience independently 
related to incident CVD in the sub-cohort.
Epidemiological research conducted among male 
and female study populations support a link between 
psychosocial factors and CVD.18,19 For example, a 
London-based study of psychological distress in 4374 
men and 1895 women reported increased risk of cor-
onary heart disease associated with higher baseline 
levels of psychological distress; associations among 
women were of a smaller magnitude compared with 
men.20 In the INTERHEART study, a large, international, 
case-control study, general stress, adverse life events, 
and financial stress were consistently associated with 
myocardial infarction risk, independent of smoking 
behavior and socioeconomic status for both men and 
women.21 Moreover, adverse childhood events, depres-
sion, and anger were more strongly related to ischemic 
heart disease risk than traditional risk factors in a study 
including 9367 women and 7970 men.22 However, it is 
widely known that sex is an important biological vari-
able. In the female-only Nurses’ Health Study II, trauma 
and posttraumatic stress disorder were associated with 
elevated incident CVD.23 Inclusion of race along with 
female sex is a focal point in understanding the impact 
of psychosocial factors and incident CVD.
Few studies have investigated stress and CVD in 
study populations with large numbers of black women, 
which is unfortunate given that black women are dis-
proportionately affected by various psychosocial chal-
lenges, including more limited access to healthcare 
through insurance,24 generally lower median household 
income,25 less access to healthy food options,26 and high-
er exposure to crime27 when compared with white wom-
en. Moreover, there is evidence to suggest that race-
related stress is associated with cardiovascular health.28 
These factors may act independently and interactively 
to uniquely increase CVD risk among black women.
In the Jackson Heart Study cohort, a cross-sec-
tional analysis found that higher levels of stress were 
positively associated with CVD risk factors, including 
hypertension, diabetes mellitus, and obesity—findings 
consistent with our own data.29 In a prior WHI analy-
sis including women of any race, baseline reports of 
higher stressful life events and social strain were asso-
ciated with CVD; however, associations were attenu-
ated with adjustment for traditional risk factors.7 Fur-
 Untreated hypertensive 226 (9%) 269 (8%) 257 (10%) 181 (7%)
Physical activity
 Missing 128 (5%) 147 (5%) 97 (4%) 73 (3%)
 None 539 (20%) 718 (22%) 589 (24%) 512 (21%)
 >0–3.75 MET-h/wk 472 (18%) 580 (18%) 456 (18%) 407 (17%)
 3.75–8.75 MET-h/wk 520 (20%) 656 (20%) 497 (20%) 513 (21%)
 8.75–17.5 MET-h/wk 490 (18%) 531 (16%) 426 (17%) 435 (18%)
 ≥17.5 MET-h/wk 500 (19%) 588 (18%) 412 (17%) 499 (20%)
WHI trial membership
 OS 1304 (49%) 1579 (49%) 1236 (50%) 1340 (55%)
 E only  178 (7%) 239 (7%) 188 (8%) 141 (6%)
 E+P 141 (5%) 171 (5%) 113 (5%) 121 (5%)
 DM 827 (31%) 978 (30%) 739 (30%) 683 (28%)
 E+P and DM 199 (8%) 253 (8%) 201 (8%) 154 (6%)




Q1 (4) Q2 (5–6) Q3 (7–9) Q4 (10–20)
(n=2649) (n=3220) (n=2477)  (n=2439)
Table 3. Age-Specific Hazard Ratios (HRs) and 95% CIs for Associations of Stressful Life Events, Social Strain, and CVD 
Risk Among Black Women in the Women’s Health Initiative, n=10 785
Univariable Model Multivariable Model*
HR (95% CI) P Value HR (95% CI) P Value
Stressful life events (at age 55)
 Q4 (7–30) vs Q1 (0–1) 1.80 (1.27–2.54) <0.001 1.32 (0.91–1.92) 0.15
 Q3 (4–6) vs Q1 (0–1) 1.25 (0.88–1.77) 0.21 1.13 (0.78–1.63) 0.51
 Q2 (2–3) vs Q1 (0–1) 1.03 (0.72–1.46) 0.89 0.84 (0.57 –1.23) 0.36
Stressful life events (at age 65)
 Q4 (7–30) vs Q1 (0–1) 1.40 (1.16–1.68) <0.001 1.14 (0.94–1.40) 0.19
 Q3 (4–6) vs Q1 (0–1) 1.13 (0.94–1.36) 0.19 1.05 (0.86–1.28) 0.62
 Q2 (2–3) vs Q1 (0–1) 1.04 (0.86–1.26) 0.68 0.94 (0.77–1.15) 0.55
Stressful life events (at age 75)
 Q4 (7–30) vs Q1 (0–1) 1.13 (0.97–1.31) 0.11 1.01 (0.86–1.19) 0.88
 Q3 (4–6) vs Q1 (0–1) 1.04 (0.9–1.19) 0.61 0.99 (0.85–1.14) 0.85
 Q2 (2–3) vs Q1 (0–1) 1.05 (0.92–1.2) 0.45 1.04 (0.90–1.20) 0.60
Stressful life events (at age 85)
 Q4 (7–30) vs Q1 (0–1) 0.94 (0.73–1.19) 0.60 0.91 (0.70–1.18) 0.48
 Q3 (4–6) vs Q1 (0–1) 0.96 (0.77–1.20) 0.73 0.93 (0.73–1.18) 0.57
 Q2 (2–3) vs Q1 (0–1) 1.06 (0.86–1.32) 0.57 1.13 (0.90–1.43) 0.29
Stressful life events (at age 95)
 Q4 (7–30) vs Q1 (0–1) 0.79 (0.55–1.13) 0.20 0.83 (0.56–1.22) 0.34
 Q3 (4–6) vs Q1 (0–1) 0.90 (0.64–1.25) 0.53 0.89 (0.62–1.27) 0.52
 Q2 (2–3) vs Q1 (0–1) 1.08 (0.77–1.49) 0.67 1.22 (0.86–1.74) 0.26
Social strain 0.001 0.39
 Q4 (10–20) vs Q1 (4) 1.30 (1.13–1.49) 1.13 (0.97–1.31)
 Q3 (7–9) vs Q1 (4) 1.24 (1.09–1.42) 1.09 (0.95–1.25)
 Q2 (5–6) vs Q1 (4) 1.14 (1.01–1.30) 1.04 (0.90–1.21)
Diabetes mellitus status
 Yes vs no 2.61 (2.32–2.93) <0.001 2.25 (1.98–2.56) <0.001
BMI <0.001 <0.001
 <25 vs 25–29 kg/m2 0.79 (0.68–0.93) 0.79 (0.67–0.93)
  ≥30 vs 25–29 kg/m2 1.39 (1.25–1.54) 1.18 (1.06–1.32)
Physical activity <0.001 0.01
 None 1.44 (1.24–1.68) 1.27 (1.09–1.49)
 >0–3.75 vs ≥17.5 MET-h/wk 1.47 (1.26–1.72) 1.28 (1.09–1.51)
 3.75–8.75 vs ≥17.5 MET-h/wk 1.26 (1.08–1.47) 1.16 (0.99–1.37)
 8.75–17.5 vs ≥17.5 MET-h/wk 1.16 (0.98–1.36) 1.10 (0.93–1.30)
Hypertension history <0.001 <0.001
 Treated hypertensive vs never hypertensive 1.71 (1.55–1.9) 1.46 (1.31–1.63)
 Untreated hypertensive vs never hypertensive 1.44 (1.22–1.72) 1.31 (1.09–1.56)
Use of antihyperlipidemia drugs
 Yes vs no 1.42 (1.25–1.6)  <0.001 1.24 (1.09–1.41)  <0.001
Smoking status <0.001 <0.001
 Past smoker vs never smoked 1.21 (1.09–1.33) 1.24 (1.12–1.38)
 Current smoker vs never smoked 1.86 (1.62–2.13) 2.05 (1.76–2.38)
Education <0.001 <0.001
 Less than high school diploma/GED vs college 
graduate or higher
1.99 (1.72–2.31) 1.61 (1.37–1.90)
 High school diploma/GED vs college graduate or higher 1.38 (1.19–1.59) 1.14 (0.98–1.34)
 Some college vs college graduate or higher 1.27 (1.14–1.41) 1.19 (1.06–1.34)
*Adjusted for stressful life events, social strain, diabetes mellitus status, BMI, physical activity, hypertension history, use of antihyperlipidemia 
drugs, smoking status, and education.
BMI indicates body mass index; GED, general equivalency diploma; and MET, metabolic equivalent.
ther, effect modification by race was not observed 
in the prior WHI study, suggesting that associations 
were similar among white and black women. In the 
current WHI analysis of black women, we observed 
an association between baseline reports of stressful 
life events and incident CVD that was also attenuated 
in multivariable models. However, in the sub-cohort 
of women with updated assessments of stressful life 
events, the association of higher stressful life events 
and incident CVD was independent of traditional risk 
factors. Of note, women in quartiles 2 and 4 of stress-
ful life events had significantly higher CVD risk than 
women in quartile 1. The lack of a clear dose-response 
relationship might suggest that the scale used to mea-
sure stressful life events is inadequate in capturing 
the full multidimensional nature of stress. In addition, 
the WHI study assessed an acute measure of stressful 
life events, ie, events occurring in the preceding year. 
As such, we hypothesize that the age-related waning 
effect of stressful life events on incident CVD reflects 
a distance from events that no longer impact car-
diovascular health. The observation that an updated 
assessment of stressful life events (evaluated during 
Extension Study 2) was independently associated with 
CVD reinforces this concept. Additional studies with 
assessment of cumulative or chronic stress are needed 
to understand pathways that lend to modification and 
mediation of stress and disease.
The association between stress and disease was 
first introduced by Selye30 and later adapted within 
the context of specific diseases, including CVD. Stress 
is hypothesized to contribute to CVD through direct 
and indirect routes. The biological response to stress 
includes raised blood pressure, reduced insulin sensitiv-
ity, increased hemostasis, and endothelial dysfunction, 
all of which could conceivably contribute to CVD.31 
Moreover, repeated exposure to stress over time causes 
wear and tear on the body that initiates additional cas-
cades of stress and disease.31,32 Indirectly, stress might 
influence CVD-related risk factors as observed in this 
study and by others.29,33 Evidence suggesting that stress 
(eg, discrimination) is linked to disease occurrence and 
is perhaps intergenerational, places greater stakes on 
eliminating psychosocial disparities.34,35
Missing from the literature is an evaluation of resil-
ience, or the ability to bounce back or recover from 
stress in the context of black women’s cardiovascular 
health. Resilience is operationalized as the ability to 
adapt to experiences of stress or adversity and maintain 
a stable trajectory of healthy psychosocial and physical 
functioning.36 Some have demonstrated that higher lev-
els of resilience are linked with longitudinal declines in 
depressive symptoms among individuals with long-term 
physical disabilities37 and overall longevity38 in study 
populations inclusive of men and women. In another 
study, resilience was shown to significantly buffer the 
association between the co-occurrence of substance 
abuse, violence, and HIV/AIDS and depressive symp-
toms among black women.9 In the current study, we 
did not observe a direct relationship between resilience 
and incident CVD, nor did resilience modify the associa-
tion between stressful life events and incident CVD. We 
used a shortened version of the Brief Resilience Scale, 
administered to women during the WHI Extension Study 
2. Of note, the women who participated in the WHI
Extension Study 2 sub-cohort were women who were
alive and motivated to participate, likely culminating in
Figure. Plots of the multivariable-adjusted hazard ratios and 95% CIs 
for associations between baseline stressful life events and cardiovas-
cular disease (CVD) risk according to age among black women in the 
Women’s Health Initiative.  
A, Quartile 4 vs quartile 1. B, Quartile 3 vs quartile 1. C, Quartile 2 vs quartile 1.
Table 4. Characteristics of Study Participants according to Resilience, Women’s Health Initiative Observational and Clinical Trials, 
n=2765*
Resilience
Q1 (3–12) Q2 (13–15) Q3 (16–17) Q4 (18)
(n=604) (n=766) (n=500) (n=895)
Age at WHI entry mean (SD) 59.5 (6.2) 59.2 (6.1) 58.7 (6.1) 58.8 (6)
Age at Extension 2 questionnaire Mean (SD) 75.0 (6.1) 74.6 (6) 74.2 (6) 74.2 (5.9)
Stressful life events
 Q4 (5–22) 232 (38%) 226 (30%) 131 (26%) 143 (16%)
 Q3 (3–4) 143 (24%) 191 (25%) 156 (31%) 232 (26%)
 Q2 (1–2) 126 (21%) 192 (25%) 122 (24%) 272 (30%)
 Q1 (0) 103 (17%) 157 (20%) 91 (18%) 248 (28%)
Education
 Missing 6 (1%) 5 (1%) 5 (1%) 6 (1%)
 Less than high school diploma or GED 31 (5%) 25 (3%) 15 (3%) 26 (3%)
 High school diploma or GED 83 (14%) 97 (13%) 46 (9%) 83 (9%)
 Some college 252 (42%) 296 (39%) 169 (34%) 321 (36%)
 College graduate or higher 232 (38%) 343 (45%) 265 (53%) 459 (51%)
Smoking status
 Missing 7 (1%) 12 (2%) 4 (1%) 9 (1%)
 Never smoked 287 (48%) 373 (49%) 234 (47%) 449 (50%)
 Past smoker 254 (42%) 299 (39%) 205 (41%) 372 (42%)
 Current smoker 56 (9%) 82 (11%) 57 (11%) 65 (7%)
BMI
 Missing 11 (2%) 5 (1%) 5 (1%) 9 (1%)
 <25 kg/m2 94 (16%) 140 (18%) 99 (20%) 177 (20%)
 25–29 kg/m2 216 (36%) 270 (35%) 177 (35%) 342 (38%)
 ≥30 kg/m2 283 (47%) 351 (46%) 219 (44%) 367 (41%)
Hormone use
 Never 330 (55%) 422 (55%) 267 (53%) 496 (55%)
 Past user 90 (15%) 115 (15%) 73 (15%) 118 (13%)
 Current user <5 y 76 (13%) 85 (11%) 75 (15%) 94 (11%)
 Current user 5 to <10 y 49 (8%) 61 (8%) 38 (8%) 87 (10%)
 Current user ≥10 y 59 (10%) 83 (11%) 47 (9%) 100 (11%)
Type of hormone use
 Never user 330 (55%) 422 (55%) 267 (53%) 496 (55%)
 Past user of either E alone or E+P 90 (15%) 115 (15%) 73 (15%) 118 (13%)
 E alone  134 (22%) 172 (22%) 106 (21%) 194 (22%)
 E+P 50 (8%) 57 (7%) 54 (11%) 87 (10%)
Oral contraceptive use 263 (44%) 352 (46%) 258 (52%) 449 (50%)
Diabetes mellitus status
 Missing 2 (<1%) 0 0 1 (<1%)
 Yes 35 (6%) 40 (5%) 33 (7%) 45 (5%)
Use of antihyperlipidemia drugs
 Missing 48 (8%) 38 (5%) 37 (7%) 37 (4%)
 Yes 71 (12%) 93 (12%) 44 (9%) 74 (8%)
Hypertension history
 Missing 39 (6%) 31 (4%) 36 (7%) 35 (4%)
(Continued )
a healthier and nonrepresentative study population. As 
such, selection bias may underlie the null findings we 
observed here. In addition, the Brief Resilience Scale is 
limited to the individual context. Other dimensions, as 
described by the multisystemic social-ecological theory 
of resilience, including the quality of the environment39 
and resilience resources40 might be important consid-
erations for black women. Despite our null findings, 
future studies should explore these features.
Traditional health behavioral interventions for ideal 
cardiovascular health include smoking cessation, healthy 
diet, and physical activity; greatest CVD risk reduction 
is achieved when such interventions are concurrent.41 
On the other hand, the extent to which interventions 
to reduce stress result in lower incidence of CVD events 
is questionable based on limited success when popu-
lation-wide strategies are implemented.42 However, 
intervening on intermediary factors downstream of 
stress (eg, physical activity) that are also implicated in 
CVD cause may be a positive strategy to simultaneously 
reduce stress and CVD risk. Future studies among black 
women are needed to test these mediation hypotheses 
and to inform future intervention studies.
Strengths of our study include the large sample size 
of black women, prospective design, use of previously 
validated stressful life events and social strain measures, 
and adjudication of clinical endpoints for all women 
included in this study. Further, this is the first study to 
examine the direct and moderating effects of resilience 
in relation to CVD among black women, which repre-
sents an important extension of the current literature.
Limitations of our study center on the scales used to 
characterize stress and resilience. Specifically, the stress-
ful life events scale queries respondents on the occur-
rence of certain events during the 1-year interval before 
questionnaire completion. This one-year duration likely 
marks an acute as opposed to chronic or cumulative 
measure of stress. As such, we cannot make conclu-
sions regarding chronic stress, which has been linked 
with higher CVD.43 Moreover, we used the stressful life 
events scale as a composite; however, not all of the indi-
vidual stressors queried therein are equal. It is possible 
that some of the stressors may be more impactful and 
detrimental to CV health (eg, financial stressors) than 
others, even if the respondent does not endorse worry-
ing about it a great deal. Further, the stressful life events 
scale does not include discrimination or perceived rac-
ism domains, which might be more relevant for black 
women. We also lacked multiple repeat measurements 
for our main exposures, preventing an assessment how 
stress, strain, and resilience change over time and the 
potential impact on CVD risk. As part of our analytic 
approach, we chose to categorize stress and strain into 
quartiles. However, due to the skewed distributions of 
both stress and strain, the highest quartiles contained 
a wide range of responses, particularly for stress (range 
for the highest quartile, 7–30). Our analyses assumed 
that the relationship between stress/strain and incident 
 Never hypertensive 286 (47%) 395 (52%) 252 (50%) 487 (54%)
 Treated hypertensive 217 (36%) 288 (38%) 175 (35%) 299 (33%)
 Untreated hypertensive 62 (10%) 52 (7%) 37 (7%) 74 (8%)
Physical activity
 Missing 33 (5%) 27 (4%) 33 (7%) 30 (3%)
 None 122 (20%) 158 (21%) 93 (19%) 191 (21%)
 >0–3.75 MET-h/wk 95 (16%) 122 (16%) 71 (14%) 113 (13%)
 3.75–8.75 MET-h/wk 132 (22%) 142 (19%) 95 (19%) 178 (20%)
 8.75–17.5 MET-h/wk 119 (20%) 153 (20%) 95 (19%) 175 (20%)
 ≥17.5 MET-h/wk 103 (17%) 164 (21%) 113 (23%) 208 (23%)
WHI trial membership
 OS 248 (41%) 342 (45%) 228 (46%) 425 (47%)
 E only  37 (6%) 44 (6%) 30 (6%) 55 (6%)
 E+P 27 (4%) 33 (4%) 28 (6%) 50 (6%)
 DM 236 (39%) 268 (35%) 174 (35%) 293 (33%)
 E+P and DM 56 (9%) 79 (10%) 40 (8%) 72 (8%)
*Demographics are restricted to the 2765 participants with available resilience information from Extension Study 2.
BMI, body mass index; DM, dietary modification; E, estrogen; GED, general equivalency diploma; MET, metabolic equivalent; OS, 
observational study; and P, progestin.
Table 4. Continued
Resilience
Q1 (3–12) Q2 (13–15) Q3 (16–17) Q4 (18)
(n=604) (n=766) (n=500) (n=895)
CVD for participants within each quartile was consis-
tent; unfortunately, with so few participants with higher 
stress and/or strain levels (eg, 95% of the participants 
had a composite stress sum ≤11), we were not able to 
verify this assumption.
The Brief Resilience Scale, a validated instrument for 
resilience, is a 6-item scale.16 In WHI, a modified version 
consisting of 3 items was available. It is possible that 
the modified version does not recapitulate the validated 
scale, potentially contributing to null findings about 
resilience and CVD risk. Despite this, our study is the first 
to examine this novel effect modification hypothesis in 
a large prospective cohort of black women. Finally, our 
results are of limited generalizability given the older age 
distribution and high educational attainment.
In conclusion, we observed age-related associations 
between stressful life events reported within the previ-
ous year and risk of developing CVD among black wom-
en. In the overall cohort of women, these associations 
were attenuated when conventional CVD risk factors 
were accounted. However, in the sub-cohort of women 
with updated measures, persistent relationships were 
observed. Additional studies among black women with 
diverse education and income levels across a range of 
ages are needed. In addition, the context of resilience 
should be further explored as resilience and resilience 
resources represent novel and potentially more mal-
leable CVD intervention targets.
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Stressful life events 0.02
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 Q4 (18) 60/895 3536.3 1.00
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 ≥30 kg/m2 111/1220 4614.6 1.40 (1.01–1.95)
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Hypertension history 0.99
 Never hypertensive 93/1420 5630.8 1.00
 Treated hypertensive 20/225 861.8 1.01 (0.74–1.38)
 Untreated 
hypertensive
89/979 3723.3 0.99 (0.59–1.66)
Use of antihyperlipidemia drugs 0.60
 No 176/2323 9072.2 1.00
 Yes 25/282 1070.8 0.89 (0.57–1.39)
Smoking status <0.001
 Never smoked 82/1343 5314.0 1.00
 Past smoker 102/1130 4338.4 1.48 (1.08–2.02)
 Current smoker 27/260 991.2 2.53 (1.58–4.04)
Education 0.01
 Less than high school 
diploma or GED
10/97 359.7 1.64 (0.83–3.24)
 High school diploma 
or GED
22/309 1183.3 1.02 (0.61–1.71)
 Some college 101/1038 3991.5 1.63 (1.19–2.25)
 College graduate or 
higher
81/1299 5149.5 1.00
*Analysis is restricted to the 2765 participants with available resilience 
information from Extension Study 2.
†Adjusted for stressful life events, diabetes mellitus status, BMI, physical 
activity, hypertension history, use of antihyperlipidemia drugs, smoking status, 
and education.
BMI indicates body mass index; GED, general equivalency diploma; 
and MET, metabolic equivalent.
son/Phoenix, AZ); Jean Wactawski-Wende (University at Buffalo, Buffalo, NY); 
Marian Limacher (University of Florida, Gainesville/Jacksonville, FL); Robert Wal-
lace (University of Iowa, Iowa City/Davenport, IA); Lewis Kuller (University of 
Pittsburgh, Pittsburgh, PA); Sally Shumaker (Wake Forest University School of 
Medicine, Winston-Salem, NC).
Sources of Funding
This work was supported by the National Cancer Institute (K01CA21845701A1 
to A.S. Felix and K12CA133250 to D. Addison), US Environmental Protection 
Agency Science to Achieve Results Award (RD83927501 to D.B. Hood), the 
National Heart, Lung, and Blood Institute (K01HL142848 to K. Breathett), Uni-
versity of Arizona Health Sciences, Strategic Priorities Faculty Initiative Grant 
(K. Breathett), and University of Arizona Sarver Heart Center (K. Breathett). 
The Women’s Health Initiative program is funded by the National Heart, 
Lung, and Blood Institute, National Institutes of Health, US Department of 
Health and Human Services through contracts HHSN268201600018C, HH-





1. Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, 
Mussolino ME, Hsu LL, Addou E, Engelgau MM, Gordon D. Decline in
cardiovascular mortality: possible causes and implications. Circ Res.
2017;120:366–380. doi: 10.1161/CIRCRESAHA.116.309115
2. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE,
Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coro-
nary disease, 1980-2000. N Engl J Med. 2007;356:2388–2398. doi:
10.1056/NEJMsa053935
3. Centers for Disease Control and Prevention (CDC). Decline in deaths from 
heart disease and stroke–United States, 1900–1999. MMWR Morb Mortal 
Wkly Rep. 1999;48:649–656.
4. Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular
disease in women: clinical perspectives. Circ Res. 2016;118:1273–1293.
doi: 10.1161/CIRCRESAHA.116.307547
5. Jones KM, Carter MM, Schulkin J. Racial and ethnic disparities in car-
diovascular disease: an assessment of obstetrician-gynecologists’ knowl-
edge, attitudes, and practice patterns. J Racial Ethn Health Disparities.
2015;2:256–266. doi: 10.1007/s40615-015-0088-9
6. Steptoe A, Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol.
2012;9:360–370. doi: 10.1038/nrcardio.2012.45
7. Kershaw KN, Brenes GA, Charles LE, Coday M, Daviglus ML, Denburg NL, 
Kroenke CH, Safford MM, Savla T, Tindle HA, Tinker LF, Van Horn L. As-
sociations of stressful life events and social strain with incident cardio-
vascular disease in the Women’s Health Initiative. J Am Heart Assoc. 
2014;3:e000687. doi: 10.1161/JAHA.113.000687
8. Ungar M. Researching and theorizing resilience across cultures and con-
texts. Prev Med. 2012;55:387–389. doi: 10.1016/j.ypmed.2012.07.021
9. Thurston IB, Howell KH, Kamody RC, Maclin-Akinyemi C, Mandell J. Re-
silience as a moderator between syndemics and depression in mothers
living with HIV. AIDS Care. 2018;30:1257–1264. doi: 10.1080/09540121.
2018.1446071
10. Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S,
Wang CY, Stein E, Prentice RL. Implementation of the Women’s Health
Initiative study design. Ann Epidemiol. 2003;13(9 suppl):S5–S17.
 11. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C,
Rossouw JE. The Women’s Health Initiative recruitment methods and re-
sults. Ann Epidemiol. 2003;13(9 suppl):S18–S77.
12. Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The
Women’s Health Initiative postmenopausal hormone trials: overview
and baseline characteristics of participants. Ann Epidemiol. 2003;13(9
suppl):S78–S86.
13. Design of the Women’s Health Initiative clinical trial and observational
study. The Women’s Health Initiative Study Group. Control Clin Trials. 
1998;19:61–109. https://doi.org/10.1016/S0197-2456(97)00078-0
 14. Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS. Psychoso-
cial influences on mortality after myocardial infarction. N Engl J Med. 
1984;311:552–559. doi: 10.1056/NEJM198408303110902
15. Rook KS. The negative side of social interaction: impact on psychological
well-being. J Pers Soc Psychol. 1984;46:1097–1108.
16. Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief 
resilience scale: assessing the ability to bounce back. Int J Behav Med.
2008;15:194–200. doi: 10.1080/10705500802222972
17. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, 
Gaziano JM, Frishman WH, Curb JD. Comparison of self-report, hos-
pital discharge codes, and adjudication of cardiovascular events in the
Women’s Health Initiative. Am J Epidemiol. 2004;160:1152–1158. doi:
10.1093/aje/
18. Steptoe A, Kivimäki M. Stress and cardiovascular disease: an update on
current knowledge. Annu Rev Public Health. 2013;34:337–354. doi:
10.1146/annurev-publhealth-031912-114452
 19. Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovas-
cular diseases. Annu Rev Public Health. 2005;26:469–500. doi:
10.1146/annurev.publhealth.26.021304.144542
20. Stansfeld SA, Fuhrer R, Shipley MJ, Marmot MG. Psychological distress
as a risk factor for coronary heart disease in the Whitehall II Study. Int J
Epidemiol. 2002;31:248–255.
21. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, 
Blackett KN, Sitthi-amorn C, Sato H, Yusuf S; INTERHEART investigators.
Association of psychosocial risk factors with risk of acute myocardial in-
farction in 11119 cases and 13648 controls from 52 countries (the IN-
TERHEART study): case-control study. Lancet. 2004;364:953–962. doi:
10.1016/S0140-6736(04)17019-0
22. Dong M, Giles WH, Felitti VJ, Dube SR, Williams JE, Chapman DP,
Anda RF. Insights into causal pathways for ischemic heart disease: adverse 
childhood experiences study. Circulation. 2004;110:1761–1766. doi:
10.1161/01.CIR.0000143074.54995.7F
 23. Sumner JA, Kubzansky LD, Elkind MS, Roberts AL, Agnew-Blais J,
Chen Q, Cerdá M, Rexrode KM, Rich-Edwards JW, Spiegelman D, Suglia SF, 
Rimm EB, Koenen KC. Trauma exposure and posttraumatic stress disorder 
symptoms predict onset of cardiovascular events in women. Circulation.
2015;132:251–259. doi: 10.1161/CIRCULATIONAHA.114.014492
24. Thomasson MA. Racial differences in health insurance coverage and medi-
cal expenditures in the United States: a historical perspective. Soc Sci Hist. 
2016;30:529–550.
25. Guzman GG. Household income: 2016. American community survey
briefs. US Census Bureau: Washington DC; 2017.
26. Kirkpatrick SI, Dodd KW, Reedy J, Krebs-Smith SM. Income and race/
ethnicity are associated with adherence to food-based dietary guidance
among US adults and children. J Acad Nutr Diet. 2012;112:624.e6–635.
e6. doi: 10.1016/j.jand.2011.11.012
27. Unger E, Diez-Roux AV, Lloyd-Jones DM, Mujahid MS, Nettleton JA,
Bertoni A, Badon SE, Ning H, Allen NB. Association of neighborhood
characteristics with cardiovascular health in the multi-ethnic study of
atherosclerosis. Circ Cardiovasc Qual Outcomes. 2014;7:524–531. doi:
10.1161/CIRCOUTCOMES.113.000698
28. Wyatt SB, Williams DR, Calvin R, Henderson FC, Walker ER, Winters K.
Racism and cardiovascular disease in African Americans. Am J Med Sci.
2003;325:315–331.
29. Gebreab SY, Diez-Roux AV, Hickson DA, Boykin S, Sims M, Sarpong DF,
Taylor HA, Wyatt SB. The contribution of stress to the social pattern-
ing of clinical and subclinical CVD risk factors in African Americans:
the Jackson Heart Study. Soc Sci Med. 2012;75:1697–1707. doi:
10.1016/j.socscimed.2012.06.003
 30. Selye H. Stress and the general adaptation syndrome. Br Med J.
1950;1:1383–1392.
 31. Peters A, McEwen BS. Stress habituation, body shape and cardio-
vascular mortality. Neurosci Biobehav Rev. 2015;56:139–150. doi:
10.1016/j.neubiorev.2015.07.001
32. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to
disease. Arch Intern Med. 1993;153:2093–2101.
33. Albert MA, Durazo EM, Slopen N, Zaslavsky AM, Buring JE, Silva T,
Chasman D, Williams DR. Cumulative psychological stress and cardio-
vascular disease risk in middle aged and older women: rationale, de-
sign, and baseline characteristics. Am Heart J. 2017;192:1–12. doi:
10.1016/j.ahj.2017.06.012
34. Taylor JY, Wright ML, Crusto CA, Sun YV. The Intergenerational Impact of 
Genetic and Psychological Factors on Blood Pressure (InterGEN) study: de-
sign and methods for complex DNA analysis. Biol Res Nurs. 2016;18:521–
530. doi: 10.1177/1099800416645399
35. Taylor JY, Sun YV, Barcelona de Mendoza V, Ifatunji M, Rafferty J, Fox ER,
Musani SK, Sims M, Jackson JS. The combined effects of genetic risk and
perceived discrimination on blood pressure among African Americans 
in the Jackson Heart Study. Medicine (Baltimore). 2017;96:e8369. doi: 
10.1097/MD.0000000000008369
36. Bonanno GA, Westphal M, Mancini AD. Resilience to loss and potential
trauma. Annu Rev Clin Psychol. 2011;7:511–535. doi: 10.1146/annurev- 
clinpsy-032210-104526
37. Silverman AM, Molton IR, Alschuler KN, Ehde DM, Jensen MP. Resilience
predicts functional outcomes in people aging with disability: a longitu-
dinal investigation. Arch Phys Med Rehabil. 2015;96:1262–1268. doi:
10.1016/j.apmr.2015.02.023
38. Elliott AM, Burton CD, Hannaford PC. Resilience does matter: evidence
from a 10-year cohort record linkage study. BMJ Open. 2014;4:e003917. 
doi: 10.1136/bmjopen-2013-003917
39. Ungar M, Ghazinour M, Richter J. Annual Research Review: What is resil-
ience within the social ecology of human development? J Child Psychol
Psychiatry. 2013;54:348–366. doi: 10.1111/jcpp.12025
40. Connor KM, Davidson JR. Development of a new resilience scale: the Con-
nor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18:76–
82. doi: 10.1002/da.10113
41. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL. Ideal
cardiovascular health predicts lower risks of myocardial infarction,
stroke, and vascular death across whites, blacks, and hispanics: the
northern Manhattan study. Circulation. 2012;125:2975–2984. doi:
10.1161/CIRCULATIONAHA.111.081083
42. Kivimäki M, Steptoe A. Effects of stress on the development and progres-
sion of cardiovascular disease. Nat Rev Cardiol. 2018;15:215–229. doi:
10.1038/nrcardio.2017.189
43. Kershaw KN, Diez Roux AV, Bertoni A, Carnethon MR, Everson-Rose SA,
Liu K. Associations of chronic individual-level and neighbourhood-level
stressors with incident coronary heart disease: the Multi-Ethnic Study of
Atherosclerosis. J Epidemiol Community Health. 2015;69:136–141. doi:
10.1136/jech-2014-204217
